Drug
Vancomycin (IV)
Vancomycin (IV) is a pharmaceutical drug with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 66.7%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
2(40%)
Results Posted
100%(2 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_3
1
20%
Ph phase_4
1
20%
Ph phase_2
1
20%
Ph phase_1
2
40%
Phase Distribution
2
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(2)
Terminated(1)
Detailed Status
Recruiting2
Completed2
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
66.7%
Most Advanced
Phase 4
Trials by Phase
Phase 12 (40.0%)
Phase 21 (20.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)
Trials by Status
terminated120%
recruiting240%
completed240%
Recent Activity
2 active trials
Showing 5 of 5
recruitingphase_4
Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
NCT06637332
recruitingphase_1
Novel Biomarkers of Non-IgE Immediate Hypersensitivity Drug Reactions
NCT07605806
completedphase_1
Vancomycin Dose Optimization in Obesity
NCT06601257
completedphase_2
Study of Debio 1450 for Bacterial Skin Infections
NCT02426918
terminatedphase_3
Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections
NCT00108433
Clinical Trials (5)
Showing 5 of 5 trials
NCT06637332Phase 4
Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
NCT07605806Phase 1
Novel Biomarkers of Non-IgE Immediate Hypersensitivity Drug Reactions
NCT06601257Phase 1
Vancomycin Dose Optimization in Obesity
NCT02426918Phase 2
Study of Debio 1450 for Bacterial Skin Infections
NCT00108433Phase 3
Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5